|
SHPK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.92659999995482E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.178870E-04 |
| Normal-vs-Stage2 |
2.552400E-02 |
| Normal-vs-Stage3 |
3.68689999999949E-05 |
| Normal-vs-Stage4 |
4.15990000000033E-05 |
| Stage1-vs-Stage2 |
7.716600E-01 |
| Stage1-vs-Stage3 |
1.315580E-01 |
| Stage1-vs-Stage4 |
2.810100E-02 |
| Stage2-vs-Stage3 |
2.190000E-01 |
| Stage2-vs-Stage4 |
3.212100E-02 |
| Stage3-vs-Stage4 |
2.050400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.13649999999799E-05 |
| Normal-vs-AfricanAmerican |
4.1904000000037E-05 |
| Normal-vs-Asian |
7.37999994449012E-09 |
| Caucasian-vs-AfricanAmerican |
9.516600E-01 |
| Caucasian-vs-Asian |
1.565840E-04 |
| AfricanAmerican-vs-Asian |
2.181400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04729999999653E-05 |
| Normal-vs-Female |
6.43929999999404E-05 |
| Male-vs-Female |
6.717000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.47420000004861E-06 |
| Normal-vs-Extreme_Weight |
1.28899999995991E-06 |
| Normal-vs-Obese |
2.539000E-03 |
| Normal-vs-Extreme_Obese |
2.414600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.801800E-01 |
| Normal_Weight-vs-Obese |
9.931900E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.869200E-01 |
| Extreme_Weight-vs-Obese |
1.474400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.630600E-01 |
| Obese-vs-Extreme_Obese |
5.502400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.561900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.613100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.83869000000003E-05 |
| Normal-vs-Age(81-100Yrs) |
1.000590E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.092600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.319000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.051200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.119600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.770030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.414000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.78450000000763E-05 |
| Normal-VS-Type2 PRCC |
8.386100E-04 |
| Normal-VS-KIRP CIMP |
4.79090000005122E-07 |
| Normal-VS-Unclassified PRCC |
2.461700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.232000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.561900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.546800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.302700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.507000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.116600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.810000E-04 |
| Normal-vs-N1 |
4.12889999967803E-08 |
| Normal-vs-N2 |
3.661300E-03 |
| N0-vs-N1 |
3.230200E-02 |
| N0-vs-N2 |
2.560600E-01 |
| N1-vs-N2 |
5.211600E-01 |
|
|
